- Home
- DAWN vs TK Comparison
DAWN vs TK Comparison
Compare DAWN & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- TK
- Stock Information
- Founded
- DAWN 2018
- TK 1973
- Country
- DAWN United States
- TK Bermuda
- Employees
- DAWN N/A
- TK N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- TK Marine Transportation
- Sector
- DAWN Health Care
- TK Consumer Discretionary
- Exchange
- DAWN Nasdaq
- TK Nasdaq
- Market Cap
- DAWN 624.8M
- TK 679.6M
- IPO Year
- DAWN 2021
- TK 1995
- Fundamental
- Price
- DAWN $9.14
- TK $9.70
- Analyst Decision
- DAWN Strong Buy
- TK
- Analyst Count
- DAWN 8
- TK 0
- Target Price
- DAWN $27.63
- TK N/A
- AVG Volume (30 Days)
- DAWN 1.9M
- TK 624.3K
- Earning Date
- DAWN 11-04-2025
- TK 10-29-2025
- Dividend Yield
- DAWN N/A
- TK 20.62%
- EPS Growth
- DAWN N/A
- TK N/A
- EPS
- DAWN N/A
- TK 0.88
- Revenue
- DAWN $133,672,000.00
- TK $992,518,000.00
- Revenue This Year
- DAWN $12.88
- TK N/A
- Revenue Next Year
- DAWN $48.27
- TK N/A
- P/E Ratio
- DAWN N/A
- TK $10.99
- Revenue Growth
- DAWN 31.11
- TK N/A
- 52 Week Low
- DAWN $5.64
- TK $5.65
- 52 Week High
- DAWN $16.76
- TK $9.70
- Technical
- Relative Strength Index (RSI)
- DAWN 71.77
- TK 69.44
- Support Level
- DAWN $7.11
- TK $9.30
- Resistance Level
- DAWN $7.62
- TK $9.65
- Average True Range (ATR)
- DAWN 0.47
- TK 0.29
- MACD
- DAWN 0.10
- TK 0.09
- Stochastic Oscillator
- DAWN 72.26
- TK 100.00
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.